Drug Profile
Research programme: influenza virus vaccine - sanofi pasteur
Alternative Names: Universal flu vaccine - sanofi pasteur/University of Pittsburgh; Universal flu vaccine - sanofi pasteur/Xiamen University; Universal influenza vaccine - sanofi pasteurLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator sanofi pasteur
- Developer Sanofi Pasteur; University of Pittsburgh; Xiamen University
- Class Influenza virus vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Influenza-virus-infections(Prevention) in China (Parenteral)
- 16 Jul 2016 No recent reports of development identified for research development in Influenza-virus-infections(Prevention) in France (Parenteral)
- 16 Jul 2016 No recent reports of development identified for research development in Influenza-virus-infections(Prevention) in USA (Parenteral)